Anna Berand

490 total citations
15 papers, 331 citations indexed

About

Anna Berand is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Anna Berand has authored 15 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in Anna Berand's work include Cancer Immunotherapy and Biomarkers (5 papers), Renal cell carcinoma treatment (4 papers) and Cancer, Lipids, and Metabolism (4 papers). Anna Berand is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Renal cell carcinoma treatment (4 papers) and Cancer, Lipids, and Metabolism (4 papers). Anna Berand collaborates with scholars based in Germany, Switzerland and United States. Anna Berand's co-authors include Albrecht Reichle, Reinhard Andreesen, Thomas Vogt, K. Bross, Frauke Bataille, Michael Landthaler, Karl‐Walter Jauch, Peter J. Wild, Christian Hafner and Stefan W. Krause and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Anna Berand

14 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Berand Germany	8	181	153	118	75	48	15	331
Simona Borštnar Slovenia	12	95 0.5×	154 1.0×	147 1.2×	78 1.0×	30 0.6×	42	356
Eric Schordan France	12	294 1.6×	107 0.7×	119 1.0×	86 1.1×	12 0.3×	19	482
Joana Assis Portugal	14	195 1.1×	100 0.7×	122 1.0×	63 0.8×	10 0.2×	30	392
Aya Shiba‐Ishii Japan	14	318 1.8×	102 0.7×	103 0.9×	72 1.0×	32 0.7×	28	423
Lorena Blanco Spain	13	162 0.9×	271 1.8×	95 0.8×	92 1.2×	54 1.1×	23	450
Su-Ing Hii Australia	5	203 1.1×	70 0.5×	108 0.9×	176 2.3×	20 0.4×	6	362
Shan Xu China	5	131 0.7×	267 1.7×	99 0.8×	119 1.6×	12 0.3×	7	408
Eunjin Bae South Korea	12	226 1.2×	91 0.6×	68 0.6×	45 0.6×	15 0.3×	16	337
Naoki Ogane Japan	14	205 1.1×	116 0.8×	160 1.4×	71 0.9×	12 0.3×	26	437
John Gao United States	8	155 0.9×	78 0.5×	61 0.5×	48 0.6×	22 0.5×	18	387

Countries citing papers authored by Anna Berand

Since Specialization

Citations

This map shows the geographic impact of Anna Berand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Berand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Berand more than expected).

Fields of papers citing papers by Anna Berand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Berand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Berand. The network helps show where Anna Berand may publish in the future.

Co-authorship network of co-authors of Anna Berand

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Berand. A scholar is included among the top collaborators of Anna Berand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Berand. Anna Berand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Walter, Bernhard, Martin Vogelhuber, Jochen Grassinger, et al.. (2011). Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial. Medical Oncology. 29(2). 799–805. 25 indexed citations

Walter, Bernhard, Sebastian Rogenhofer, Martin Vogelhuber, et al.. (2010). Modular therapy approach in metastatic castration-refractory prostate cancer. World Journal of Urology. 28(6). 745–750. 12 indexed citations

Meyer, Stefanie, Thomas Vogt, Michael Landthaler, et al.. (2009). Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant Melanoma. PPAR Research. 2010. 1–11. 35 indexed citations

Reichle, Albrecht, Claudia Ott, Frank Klebl, et al.. (2009). Control of cancer-associated inflammation and survival: Results from a prospective randomized phase II trial in gastric cancer. Journal of Clinical Oncology. 27(15_suppl). e15584–e15584. 3 indexed citations

Reichle, Albrecht, Thomas Vogt, Brigitte Coras, et al.. (2007). Targeted combined anti-inflammatory and angiostatic therapy in advanced melanoma: a randomized phase II trial. Melanoma Research. 17(6). 360–364. 33 indexed citations

Reichle, Albrecht, Jochen Grassinger, K. Bross, et al.. (2007). C-reactive Protein in Patients with Metastatic Clear Cell Renal Carcinoma: An Important Biomarker for Tumor-associated Inflammation.. PubMed. 1. 87–98. 16 indexed citations

Reichle, Albrecht, Bernhard Walter, Anna Berand, et al.. (2007). Induction of complete remission in metastatic hormone-refractory prostate cancer: A combined anti-inflammatory therapy approach. Journal of Clinical Oncology. 25(18_suppl). 15636–15636. 1 indexed citations

Reichle, Albrecht, et al.. (2007). Inclusion of High-Dose Treosulfan Followed by Autologous Transplantation in the Tandem Transplantation for Patients with Multiple Myeloma <60 Years.. Blood. 110(11). 5098–5098. 1 indexed citations

Reichle, Albrecht, Jochen Grassinger, K. Bross, et al.. (2006). Effect of anti-inflammatory therapy in patients with metastatic renal cell carcinoma on clinical response. Journal of Clinical Oncology. 24(18_suppl). 14500–14500.

10.

Reichle, Albrecht, Jochen Grassinger, K. Bross, et al.. (2006). C-reactive Protein in Patients with Metastatic Clear Cell Renal Carcinoma: An Important Biomarker for Tumor-associated Inflammation. Biomarker Insights. 1. 2137016740–2137016740. 7 indexed citations

11.

Reichle, Albrecht, Ernst Holler, Anna Berand, & Reinhard Andreesen. (2005). Treosulfan-Based Tandem High-Dose Chemo-Immuno- Therapy with Autologous Stem Cell Transplantation for Relapsed and Refractory Aggressive B-Cell Lymphomas.. Blood. 106(11). 5488–5488. 2 indexed citations

12.

Reichle, Albrecht, K. Bross, Thomas Vogt, et al.. (2004). Pioglitazone and rofecoxib combined with angiostatically scheduled trofosfamide in the treatment of far‐advanced melanoma and soft tissue sarcoma. Cancer. 101(10). 2247–2256. 73 indexed citations

13.

Reichle, Albrecht, Frank Klebl, K. Bross, et al.. (2004). Anti-inflammatory therapy combined with angiostatic scheduling of chemotherapy in advanced biliary tract cancer, hepatocellular carcinoma and gastric cancer. Journal of Clinical Oncology. 22(14_suppl). 4175–4175. 5 indexed citations

14.

Vogt, Thomas, Christian Hafner, K. Bross, et al.. (2003). Antiangiogenetic therapy with pioglitazone, rofecoxib, and metronomic trofosfamide in patients with advanced malignant vascular tumors. Cancer. 98(10). 2251–2256. 116 indexed citations

15.

Reichle, A., Thomas Vogt, F Bataille, et al.. (2003). 1000 Pioglitazone and rofecoxib combined with angiostatic scheduling of chemotherapy in far advanced malignancies. European Journal of Cancer Supplements. 1(5). S299–S299. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact